Clinical trial
Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal…
NCT00060268 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00060268 |
|---|---|
| Title | Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors |
| Official title | A Phase I/II Trial for Treatment of Obstructive Esophageal Tumors by Photodynamic Therapy (PDT) Using 2-(1-Hydroxyethyl)-2-Devinylpyropheophorbide-a (HPPH) |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug |
| Interventions | HPPH |
| Enrollment | 11 |
| Start date | Jan 1, 1997 |
| Primary completion | Sep 1, 2003 |
| Completion | Jun 1, 2004 |
| First posted | May 7, 2003 |
| Last update posted | Mar 9, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: